Abstract
<h3>Background:</h3> Earlier publications have suggested a possible role for the efflux transporter breast cancer resistance protein (BCRP) in acquired resistance to disease-modifying antirheumatic drugs (DMARDs) such as leflunomide and its...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have